Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) major shareholder Robert M. Williams, Jr. sold 91,061 shares of the company's stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $5.84, for a total transaction of $531,796.24. Following the completion of the transaction, the insider now owns 545,330 shares in the company, valued at approximately $3,184,727.20. This represents a 14.31% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.
Aveanna Healthcare Price Performance
Aveanna Healthcare stock traded up $0.04 during midday trading on Monday, reaching $5.44. 146,723 shares of the company traded hands, compared to its average volume of 269,838. The firm has a market capitalization of $1.06 billion, a price-to-earnings ratio of -16.03 and a beta of 2.01. The business has a 50 day moving average of $4.84 and a two-hundred day moving average of $4.89. Aveanna Healthcare Holdings Inc. has a 12 month low of $2.32 and a 12 month high of $6.19.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in AVAH. Barclays PLC boosted its stake in shares of Aveanna Healthcare by 80.1% during the 3rd quarter. Barclays PLC now owns 122,689 shares of the company's stock worth $637,000 after acquiring an additional 54,557 shares during the last quarter. JPMorgan Chase & Co. increased its position in Aveanna Healthcare by 266.4% in the third quarter. JPMorgan Chase & Co. now owns 85,714 shares of the company's stock worth $446,000 after buying an additional 62,319 shares in the last quarter. SG Americas Securities LLC raised its stake in shares of Aveanna Healthcare by 26.0% in the fourth quarter. SG Americas Securities LLC now owns 24,366 shares of the company's stock worth $111,000 after buying an additional 5,031 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in shares of Aveanna Healthcare by 15.7% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 25,171 shares of the company's stock worth $115,000 after buying an additional 3,407 shares during the period. Finally, Legato Capital Management LLC bought a new position in shares of Aveanna Healthcare in the fourth quarter worth about $83,000. 87.96% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
AVAH has been the topic of several analyst reports. UBS Group upped their target price on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a research note on Friday. Truist Financial lowered their price objective on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a research report on Friday, April 11th.
Get Our Latest Research Report on Aveanna Healthcare
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.